Central retinal-artery occlusion in a patient with circulating lupus anticoagulant.
The circulating lupus anticoagulant is a spontaneously acquired immunoglobulin that has been associated in vivo with an increased risk of thrombotic episodes. We describe the case of a young woman with central retinal-artery occlusion associated with circulating lupus anticoagulant in the absence of systemic lupus erythematosus or any other autoimmune or collagen vascular disease. In cases of central retinal-artery occlusion without apparent cause, the presence of the lupus anticoagulant should be excluded especially in cases that have been exposed to the human immunodeficiency virus.
Reisin
L H
LH
Cardiological Unit, Barzilai Medical Center, Ashkelon, Israel.
Reisin
I
I
Darawshi
A
A
Aviel
E
E
D000293:Adolescent; D001779:Blood Coagulation Factors / Q000032:analysis / Q000276:immunology*; D005260:Female; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D007429:Intraocular Pressure; D016682:Lupus Coagulation Inhibitor; D010314:Partial Thromboplastin Time; D015356:Retinal Artery Occlusion / Q000209:etiology*; D014792:Visual Acuity
D001779:Blood Coagulation Factors; D016682:Lupus Coagulation Inhibitor